Default company panoramic image
Logo

NatCure Sciences, Inc.

NatCure, a private start-up company, seeks funding for drug development of a plant-derived compound for autoimmune disease treatment

  • Stage Product In Development
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded March 2010
  • Employees 4
  • Website natcure.com

Company Summary

NatCure Sciences is a biopharmaceutical discovery company developing drug products isolated from plant extracts with history in traditional medicine from Africa and China. The lead product NAT-100 is being developed to treat Inflammatory Bowel Disease (IBD) and Multiple Sclerosis (MS). The active NAT-100 compound is water soluble with anti-inflammatory and immunosuppressive activity with little or no known-toxicity in man.

Team

  • Default avatar
    Harout DerSimonian, PhD
    Founder and CEO/CSO

    Former assistant professor at Harvard Medical School and assistant immunologist at Massachusetts General Hospital. 20+ years of research and development experience in biotechnology with expertise in autoimmunity and transplantationdevelopment experience in biotechnology with expertise in autoimmunity and transplantation

  • Default avatar
    Abdellah Sentissi, PhD
    VP, Drug Development and Quality Management

    Chemist, Pharmacist, and Biologist with 20+ years experience in creating and managing quality control laboratories and developing and implementing quality systems for biotechnology companies. Extensive experience in pharmaceutical Sciences with expertise in Quality Assurance and Drug Development

  • Default avatar
    Christopher Braudis Jr, MSc, RQAP-GLP
    Director of Operations

    Experienced professional in GxP regulations, Quality Assurance, Regulatory Affairs, Auditing, Computer System Validation, Bioanalytical Method Validation, and Bioanalytical Sample Analysis

Advisors

  • Default avatar
    Jeffrey L. Quillen, Foley Hoag LLP
    Lawyer
    Unconfirmed
    Default avatar
    Robert Baker, Baker O'Connor & Co
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Harout DerSimonian - founder
    Unconfirmed
    Default avatar
    American Chemical Society - ACS Entrepreneurial Initiative
    Unconfirmed